相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Robust Determination of the Optimal Continuous Glucose Monitoring Length of Intervention to Evaluate Long-Term Glycemic Control
Pau Herrero et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2021)
Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology
Jordan E. Pinsker et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2021)
Time in range: A best practice guide for UK diabetes healthcare professionals in the context of the COVID-19 global pandemic
E. G. Wilmot et al.
DIABETIC MEDICINE (2021)
The Added and Interpretative Value of CGM-Derived Parameters in Type 1 Diabetes Depends on the Level of Glycemic Control
Simon Helleputte et al.
ENDOCRINE PRACTICE (2021)
HbA1c and Glucose Management Indicator Discordance: A Real-World Analysis
Jordan E. Perlman et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2021)
Characteristics of Continuous Glucose Monitoring Metrics in Persons with Type 1 and Type 2 Diabetes Treated with Multiple Daily Insulin Injections
Sara Hallstrom et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2021)
Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop Trial
Elvira Isganaitis et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2021)
A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial
Richard M Bergenstal et al.
LANCET (2021)
Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 Diabetes
Olivia J. Collyns et al.
DIABETES CARE (2021)
Time in range centered diabetes care
Klemen Dovc et al.
CLINICAL PEDIATRIC ENDOCRINOLOGY (2021)
Time in Range Is Associated with Carotid Intima-Media Thickness in Type 2 Diabetes
Jingyi Lu et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2020)
Positioning time in range in diabetes management
Andrew Advani
DIABETOLOGIA (2020)
Glycemic Targets: Standards of Medical Care in Diabetes-2020
DIABETES CARE (2020)
Respective Contributions of Glycemic Variability and Mean Daily Glucose as Predictors of Hypoglycemia in Type 1 Diabetes: Are They Equivalent?
Louis Monnier et al.
DIABETES CARE (2020)
Diabetes Technology: Standards of Medical Care in Diabetes-2020
DIABETES CARE (2020)
Glycemic variability modifies the relationship between time in range and hemoglobin A1c estimated from continuous glucose monitoring: A preliminary study
Jingyi Lu et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Glucose Time In Range, Time Above Range, and Time Below Range Depend on Mean or Median Glucose or HbA1c, Glucose Coefficient of Variation, and Shape of the Glucose Distribution
David Rodbard
DIABETES TECHNOLOGY & THERAPEUTICS (2020)
Time in Range in Children with Type 1 Diabetes Using Treatment Strategies Based on Nonautomated Insulin Delivery Systems in the Real World
Valentino Cherubini et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2020)
HbA1c The Glucose Management Indicator, Time in Range, and Standardization of Continuous Glucose Monitoring Reports in Clinical Practice
Anders L. Carlson et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2020)
Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease
Laura Mayeda et al.
BMJ OPEN DIABETES RESEARCH & CARE (2020)
Association Between Continuous Glucose Monitoring-Derived Time in Range, Other Core Metrics, and Albuminuria in Type 2 Diabetes
Jee Hee Yoo et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2020)
Derived Time-in-Range Is Associated with MACE in T2D: Data from the DEVOTE Trial
Richard M. Bergenstal et al.
DIABETES (2020)
TIR generated by continuous glucose monitoring is associated with peripheral nerve function in type 2 diabetes
Fengwen Li et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Improved Time in Range Over 1 Year Is Associated With Reduced Albuminuria in Individuals With Sensor-Augmented Insulin Pump-Treated Type 1 Diabetes
Ajenthen G. Ranjan et al.
DIABETES CARE (2020)
Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control
Jee Hee Yoo et al.
DIABETES & METABOLISM JOURNAL (2020)
Connecting the Dots: Validation of Time in Range Metrics With Microvascular Outcomes
Irl B. Hirsch et al.
DIABETES CARE (2019)
Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies
Karl Kristensen et al.
DIABETOLOGIA (2019)
Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study
Viral N. Shah et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino et al.
DIABETES CARE (2019)
Utilizing the Ambulatory Glucose Profile to Standardize and Implement Continuous Glucose Monitoring in Clinical Practice
Mary L. Johnson et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2019)
Associations between HbA1c and continuous glucose monitoring-derived glycaemic variables
I. B. Hirsch et al.
DIABETIC MEDICINE (2019)
Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters
Helen R. Murphy
DIABETOLOGIA (2019)
Random plasma glucose predicts the diagnosis of diabetes
Mary K. Rhee et al.
PLOS ONE (2019)
Glycaemic variability in diabetes: clinical and therapeutic implications
Antonio Ceriello et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials
Roy W. Beck et al.
DIABETES CARE (2019)
The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes
Robert A. Vigersky et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2019)
Need for Regulatory Change to Incorporate Beyond A1C Glycemic Metrics
Charles M. Alexander et al.
DIABETES CARE (2018)
Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control
Tonya D. Riddlesworth et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2018)
Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes
Jingyi Lu et al.
DIABETES CARE (2018)
Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring
Richard M. Bergenstal et al.
DIABETES CARE (2018)
ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes
Linda A. DiMeglio et al.
PEDIATRIC DIABETES (2018)
Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Stephanie A. Amiel et al.
DIABETES CARE (2017)
Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes
Louis Monnier et al.
DIABETES CARE (2017)
Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial
Denice S. Feig et al.
LANCET (2017)
Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange
Gina Agiostratidou et al.
DIABETES CARE (2017)
International Consensus on Use of Continuous Glucose Monitoring
Thomas Danne et al.
DIABETES CARE (2017)
Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels
Richard M. Bergenstal et al.
ANNALS OF INTERNAL MEDICINE (2017)
Interference of Hb D-Los Angeles on the measurement of glycated hemoglobin. A case report
Pedro Jose Pines Corrales et al.
ENDOCRINOLOGIA DIABETES Y NUTRICION (2017)
Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters
Lorena Alarcon-Casas Wright et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2017)
Are There Clinical Implications of Racial Differences in HbA1c? A Difference, to Be a Difference, Must Make a Difference
Elizabeth Selvin
DIABETES CARE (2016)
Time in Range: A Fourth Domain in Glycemic Control or a Glucose Variability Alternative?
Amr S. Omar
MAYO CLINIC PROCEEDINGS (2016)
Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!
Irl B. Hirsch
DIABETES CARE (2015)
Glycemic Variability and Diabetes Complications: Does It Matter? Simply Put, There Are Better Glycemic Markers!
Richard M. t Bergenstal
DIABETES CARE (2015)
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview
David M. Nathan
DIABETES CARE (2014)
Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (AGP)
Richard M. Bergenstal et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2013)
HbA1c: A Review of Analytical and Clinical Aspects
Cas Weykamp
ANNALS OF LABORATORY MEDICINE (2013)
Optimal Sampling Intervals to Assess Long-Term Glycemic Control Using Continuous Glucose Monitoring
Dongyuan Xing et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
Iron-deficiency anemia, non-iron-deficiency anemia and HbA1c among adults in the US
Earl S. Ford et al.
JOURNAL OF DIABETES (2011)
Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus
Boyd E. Metzger et al.
DIABETES CARE (2007)
HbA1c levels are significantly lower in early and late pregnancy
LR Nielsen et al.
DIABETES CARE (2004)
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
IM Stratton et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
分享论文
